Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Heiligenstein, S. Hoog, K. Wagner, R. Findling, Nora Galil, S. Kaplan, J. Busner, M. Nilsson, E. Brown, J. Jacobson (2006)
Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study.Journal of child and adolescent psychopharmacology, 16 1-2
T. Mayes, R. Tao, J. Rintelmann, T. Carmody, C. Hughes, B. Kennard, S. Stewart, G. Emslie (2007)
Do Children and Adolescents Have Differential Response Rates in Placebo-Controlled Trials of Fluoxetine?CNS Spectrums, 12
G. Emslie, J. Heiligenstein, K. Wagner, S. Hoog, D. Ernest, E. Brown, M. Nilsson, J. Jacobson (2002)
Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.Journal of the American Academy of Child and Adolescent Psychiatry, 41 10
G. Emslie, A. Rush, W. Weinberg, R. Kowatch, C. Hughes, T. Carmody, J. Rintelmann (1997)
A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.Archives of general psychiatry, 54 11
DeFilippis (2014)
Management of treatment - resistant depression in children and adolescents PaediatrDrugs, 16
S. Corya, D. Williamson, T. Sanger, S. Briggs, M. Case, G. Tollefson (2006)
A randomized, double‐blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment‐resistant depressionDepression and Anxiety, 23
H. Detke, M. DelBello, J. Landry, R. Usher (2015)
Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.Journal of the American Academy of Child and Adolescent Psychiatry, 54 3
(2012)
Spiritualita pacientov s vybranymi psychiatrickymi diagnozami. Osetrovatelstvi a porodni asistence
Melissa DeFilippis, K. Wagner (2014)
Management of Treatment-Resistant Depression in Children and AdolescentsPediatric Drugs, 16
R. Glass (2005)
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial.The Journal of pediatrics, 146 1
B. Kennard, Susan Silva, B. Vitiello, J. Curry, C. Kratochvil, A. Simons, Jennifer Hughes, N. Feeny, E. Weller, M. Sweeney, M. Reinecke, S. Pathak, Golda Ginsburg, G. Emslie, J. March (2006)
Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).Journal of the American Academy of Child and Adolescent Psychiatry, 45 12
(2016)
Liečba psychofarmakami vdetskom aadolescentnom veku. In: Psychofarmakológia
References[1] American psychiatric association. Diagnostic and statistical manual of mental disorders. DSM-5. 5th ed. Arlington, VA: American Psychiatric Association; 2013. ISBN 978-0-89042-554-1.[2] Corya SA, Williamson D, Sanger TM, Briggs SD, et al. (2006). A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression. Depress Anxiety 23:364–372.10.1002/da.20130[3] DeFilippis M, Wagner KD. Management of treatment-resistant depression in children and adolescents. Paediatr Drugs. 2014 Oct;16(5):353-61.10.1007/s40272-014-0088-y[4] Detke HC, Delbello MP, Landry J, Usher RW. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2015;54(3):217–224.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000350709000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3[5] Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002; 41 (10): 1205-1215.[6] Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54 (11): 1031-1037.10.1001/archpsyc.1997.01830230069010[7] Farsky I, Smetanka A, Dubinska S. Spiritualita pacientov s vybranymi psychiatrickymi diagnozami. Osetrovatelstvi a porodni asistence. 2012;3(3):433–441.[8] Food and drug administration (FDA). Antidepressant Medications: Use in Pediatric Patients. 2015. In https://www.cms.gov/Medicare-Medicaid-Coordination/Fraud-Prevention/Medicaid-Integrity-Education/Pharmacy-Education-Materials/Downloads/ad-pediatric-factsheet11-14.pdf[9] Heiligenstein JH, Hoog SL, Wagner KD, Findling RL, et al. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):207-17.[10] Kennard B, Silva S, Vitiello B, Curry J, et al. TADS Team. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1404-11.[11] March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004; 292 (7): 807-820.[12] Mayes TL, Tao R, Rintelmann JW, Carmody T, et al. Do children and adolescents have differential response rates in placebo-controlled trials of fluoxetine? CNS Spectr. 2007 Feb;12(2):147-54.10.1017/S1092852900020666[13] Ondrejka I. Liečba psychofarmakami vdetskom aadolescentnom veku. In: Psychofarmakológia. Vyd. Wolters Kluwer, 2016. S. 467-502. ISBN: 978-80-8168-543-9.
Acta Facultatis Pharmaceuticae Universitatis Comenianae – de Gruyter
Published: Sep 1, 2017
You can share this free article with as many people as you like with the url below! We hope you enjoy this feature!
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.